The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions. By leveraging SCOPE’s knowledge and expertise in eye drop product formulation science, together with CEVR’s experience in ocular drug discovery and delivery translational research, the pair are committed to developing innovative product approaches for practitioner and patient unmet ocular surface disease needs.